Gts Securities LLC Biotechnology

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$29.2 Million
27.8K
Q3 2024
Reduced 43.22%
MRNA
Moderna, Inc.
PUT
$28.1 Million
421K
Q3 2024
Added 140.41%
MRNA
Moderna, Inc.
CALL
$14 Million
210K
Q3 2024
Added 140.41%
NVO
Novo Nordisk A S
PUT
$12.2 Million
103K
Q3 2024
Reduced 17.61%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$12.2 Million
11.6K
Q3 2024
Reduced 43.22%
NVO
Novo Nordisk A S
CALL
$11.4 Million
96K
Q3 2024
Reduced 17.61%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$7.84 Million
28.5K
Q3 2024
Added 648.45%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$7.48 Million
27.2K
Q3 2024
Added 648.45%
VRTX
Vertex Pharmaceuticals Inc
CALL
$6.56 Million
14.1K
Q3 2024
Added 124.35%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$5.77 Million
27.2K
Q3 2024
Added 289.65%
VRTX
Vertex Pharmaceuticals Inc
PUT
$5.26 Million
11.3K
Q3 2024
Added 124.35%
BNTX
Bio N Tech Se
PUT
$4.61 Million
38.8K
Q3 2024
Added 358.89%
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$4.44 Million
20.9K
Q3 2024
Added 289.65%
SAVA
Cassava Sciences Inc
CALL
$4.17 Million
142K
Q2 2023
New holding
BMRN
Biomarin Pharmaceutical Inc
PUT
$3.77 Million
53.6K
Q3 2024
Added 55.0%
SAVA
Cassava Sciences Inc
PUT
$3.47 Million
118K
Q2 2023
New holding
NVAX
Novavax Inc
PUT
$3.36 Million
266K
Q3 2024
New holding
VKTX
Viking Therapeutics, Inc.
CALL
$3.03 Million
47.9K N/A
CRSP
Crispr Therapeutics Ag
PUT
$2.79 Million
59.3K
Q3 2024
Added 25.23%
AXSM
Axsome Therapeutics, Inc.
CALL
$2.46 Million
27.4K
Q3 2024
Reduced 13.71%
SRPT
Sarepta Therapeutics, Inc.
CALL
$2.42 Million
19.4K
Q3 2024
Added 7.62%
NVAX
Novavax Inc
CALL
$2.38 Million
189K
Q3 2024
New holding
BPMC
Blueprint Medicines Corp
CALL
$2.25 Million
24.3K N/A
BNTX
Bio N Tech Se
CALL
$2.09 Million
17.6K
Q3 2024
Added 358.89%
TGTX
Tg Therapeutics, Inc.
PUT
$1.88 Million
80.4K
Q3 2024
Reduced 10.69%
CYTK
Cytokinetics Inc
CALL
$1.87 Million
35.5K
Q4 2023
Added 1526.34%
TGTX
Tg Therapeutics, Inc.
CALL
$1.86 Million
79.4K
Q3 2024
Reduced 10.69%
SMMT
Summit Therapeutics Inc.
PUT
$1.76 Million
80.5K
Q3 2024
New holding
UTHR
United Therapeutics Corp
CALL
$1.68 Million
4.7K
Q2 2024
New holding
MNKD
Mannkind Corp
PUT
$1.48 Million
235K
Q2 2024
Added 45.7%
EXEL
Exelixis, Inc.
CALL
$1.22 Million
47K
Q2 2024
Reduced 43.64%
UTHR
United Therapeutics Corp
PUT
$1.18 Million
3.3K
Q2 2024
New holding
PCVX
Vaxcyte, Inc.
CALL
$1.11 Million
9.7K
Q3 2024
New holding
AXSM
Axsome Therapeutics, Inc.
PUT
$1.11 Million
12.3K
Q3 2024
Reduced 13.71%
INSM
Insmed Inc
CALL
$1.07 Million
14.6K
Q2 2024
New holding
ACLX
Arcellx, Inc.
PUT
$1.06 Million
12.7K
Q3 2024
New holding
LQDA
Liquidia Corp
CALL
$894,000
89.4K
Q3 2024
Added 3.1%
SMMT
Summit Therapeutics Inc.
CALL
$851,000
38.9K
Q3 2024
New holding
CYTK
Cytokinetics Inc
PUT
$818,000
15.5K
Q4 2023
Added 1526.34%
AUPH
Aurinia Pharmaceuticals Inc.
PUT
$780,000
107K
Q3 2024
Added 65.49%
INCY
Incyte Corp
PUT
$779,000
11.8K
Q3 2024
Reduced 15.6%
CAPR
Capricor Therapeutics, Inc.
CALL
$769,000
50.6K N/A
MLTX
Moon Lake Immunotherapeutics
CALL
$756,000
15K N/A
CRSP
Crispr Therapeutics Ag
CALL
$751,000
16K
Q3 2024
Added 25.23%
BPMC
Blueprint Medicines Corp
PUT
$674,000
7.3K N/A
CAPR
Capricor Therapeutics, Inc.
PUT
$617,000
40.6K N/A
BBIO
Bridge Bio Pharma, Inc.
CALL
$565,000
22.2K N/A
BCRX
Biocryst Pharmaceuticals Inc
CALL
$562,000
74K
Q2 2024
Added 421.51%
INCY
Incyte Corp
CALL
$548,000
8.3K
Q3 2024
Reduced 15.6%
Filter Shares Options
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email